State-Of-The-Art Treatment in Castration-Resistant Prostate Cancer

Abstract

Prostate cancer (PrCa) is the most common cancer type in men in developed countries. In the last few years, a dramatic change has occurred in the understanding of castration-resistant PrCa which has led to the development of new drugs that have an impact on patient survival. This review summarises the recent advances in the management of the disease.

Keywords

• Bladder Cancer
• Renal Cancer
• testicular cancer
• treatment options